Daniel  Raskas net worth and biography

Daniel Raskas Biography and Net Worth

SVP of Danaher
As Senior Vice President, Corporate Development, Daniel Raskas leads mergers and acquisitions in partnership with Bill King and oversees investment activity, including identification, valuation, due diligence, contract strategy and negotiations.

Daniel joined Danaher in 2004, originally serving as Vice President of Corporate Development, and was promoted to his current role in 2010. Throughout his tenure, he has led business development across the company and overseen a number of major acquisitions, including Beckman Coulter, Pall and Cytiva.

Before joining Danaher, Daniel was a partner at Thayer Capital Partners, a private equity firm focused on buyout and growth equity investments in the middle market. He also served as an associate at Arnold & Porter LLP for several years, where he specialized in transactional work including M&A and public offerings.

Daniel received a B.A. in Government from Harvard College, an M.B.A. from Columbia University School of International and Public Affairs, and a J.D. from Harvard Law School.

What is Daniel Raskas' net worth?

The estimated net worth of Daniel Raskas is at least $8.33 million as of July 28th, 2023. Mr. Raskas owns 38,288 shares of Danaher stock worth more than $8,327,257 as of December 11th. This net worth approximation does not reflect any other investments that Mr. Raskas may own. Learn More about Daniel Raskas' net worth.

How old is Daniel Raskas?

Mr. Raskas is currently 56 years old. There are 6 older executives and no younger executives at Danaher. The oldest executive at Danaher is Mr. Steven M. Rales, Co-Founder & Chairman, who is 72 years old. Learn More on Daniel Raskas' age.

How do I contact Daniel Raskas?

The corporate mailing address for Mr. Raskas and other Danaher executives is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. Danaher can also be reached via phone at (202) 828-0850 and via email at [email protected]. Learn More on Daniel Raskas' contact information.

Has Daniel Raskas been buying or selling shares of Danaher?

Daniel Raskas has not been actively trading shares of Danaher over the course of the past ninety days. Most recently, Daniel Raskas sold 11,213 shares of the business's stock in a transaction on Friday, July 28th. The shares were sold at an average price of $260.65, for a transaction totalling $2,922,668.45. Following the completion of the sale, the senior vice president now directly owns 38,288 shares of the company's stock, valued at $9,979,767.20. Learn More on Daniel Raskas' trading history.

Who are Danaher's active insiders?

Danaher's insider roster includes Rainer Blair (EVP), Daniel Comas (EVP), William Daniel (EVP), Brian Ellis (SVP), Linda Filler (Director), Jose-Carlos Gutierrez-Ramos (SVP), Linda Hefner (Director), Jennifer Honeycutt (EVP), Thomas Joyce, Jr. (CEO), William King (SVP), Angela Lalor (SVP), Angela Lalor (SVP), Teri List (Director), Walter Lohr (Director), Robert Lutz (CAO), Matthew McGrew (CFO), Mitchell Rales (Chairman), Daniel Raskas (SVP), John Schwieters (Director), Alan Spoon (Director), Raymond Stevens (Director), Joakim Weidemanis (EVP), and Elias Zerhouni (Director). Learn More on Danaher's active insiders.

Are insiders buying or selling shares of Danaher?

In the last twelve months, insiders at the conglomerate sold shares 11 times. They sold a total of 90,798 shares worth more than $22,878,524.16. The most recent insider tranaction occured on August, 21st when SVP Jose-Carlos Gutierrez-Ramos sold 590 shares worth more than $147,818.60. Insiders at Danaher own 11.1% of the company. Learn More about insider trades at Danaher.

Information on this page was last updated on 8/21/2023.

Daniel Raskas Insider Trading History at Danaher

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/28/2023Sell11,213$260.65$2,922,668.4538,288View SEC Filing Icon  
5/31/2023Sell19,847$228.50$4,535,039.5038,673View SEC Filing Icon  
11/26/2021Sell12,300$325.33$4,001,559.00View SEC Filing Icon  
10/23/2020Sell28,389$234.50$6,657,220.5038,850View SEC Filing Icon  
5/8/2020Sell37,082$164.09$6,084,785.3819,723View SEC Filing Icon  
11/16/2017Sell37,870$93.33$3,534,407.10View SEC Filing Icon  
2/26/2016Sell4,656$89.00$414,384.0017,786View SEC Filing Icon  
2/26/2015Sell4,179$87.79$366,874.41View SEC Filing Icon  
2/20/2015Sell56,000$87.03$4,873,680.00View SEC Filing Icon  
5/1/2014Sell11,158$73.48$819,889.8418,368View SEC Filing Icon  
10/18/2013Sell20,000$71.99$1,439,800.00View SEC Filing Icon  
7/24/2013Sell20,000$67.54$1,350,800.00View SEC Filing Icon  
See Full Table

Daniel Raskas Buying and Selling Activity at Danaher

This chart shows Daniel Raskas's buying and selling at Danaher by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Danaher Company Overview

Danaher logo
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, municipal, industrial, and natural resource applications. It also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. The company was founded in 1969 and is headquartered in Washington, the District of Columbia.
Read More

Today's Range

Now: $221.35
Low: $217.96
High: $221.70

50 Day Range

MA: $208.65
Low: $185.10
High: $223.48

2 Week Range

Now: $221.35
Low: $182.09
High: $249.59


2,576,101 shs

Average Volume

3,209,708 shs

Market Capitalization

$163.56 billion

P/E Ratio


Dividend Yield